Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
23.85
0.52 (2.23%)
At close: Aug 18, 2025, 3:59 PM
23.87
0.08%
After-hours: Aug 18, 2025, 04:42 PM EDT
2.23% (1D)
| Bid | 22.12 |
| Market Cap | 345.25M |
| Revenue (ttm) | 200K |
| Net Income (ttm) | 1.72B |
| EPS (ttm) | -16.57 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | -2.29 |
| Analyst | n/a |
| Ask | 26 |
| Volume | 68,665 |
| Avg. Volume (20D) | 107,272 |
| Open | 23.26 |
| Previous Close | 23.33 |
| Day's Range | 22.69 - 23.96 |
| 52-Week Range | 10.80 - 25.29 |
| Beta | 0.22 |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
3 months ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
9 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...